Literature DB >> 15250224

Pulmonary function tests in preoperative pulmonary evaluation.

Jeng-Shing Wang1.   

Abstract

Pulmonary function testing (PFT) has been used to evaluate the risk for postoperative complications since the 1950s. PFT including spirometry, lung volumes, diffusing capacity, oximetry, and arterial blood gases has been used to assess the postoperative risk of lung resection. In selected cases, additional evaluation may include radionuclide lung scanning, exercise testing, invasive pulmonary hemodynamic measurements, and risk stratification analysis. A new index, predicted postoperative product (PPP), was found to have strong predictive ability for mortality. We defined a new useful index, measured product (MP), to predict postoperative complications; MP had similar advantages of PPP. Since diffusing capacity at rest has been shown to be a good predictor of postoperative complications following lung resection, and since exercise testing has been also useful in preoperative evaluation prior to lung resection, we reasoned that evaluation of the effect of exercise on diffusing capacity would be helpful to evaluate the ability of the pulmonary capillary bed to expand and increase its capacity to transfer gas during exercise.

Mesh:

Year:  2004        PMID: 15250224     DOI: 10.1016/j.rmed.2004.01.007

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  5 in total

Review 1.  Complications of lung resection and exercise capacity: a meta-analysis.

Authors:  Roberto Benzo; George A Kelley; Laura Recchi; Albert Hofman; Frank Sciurba
Journal:  Respir Med       Date:  2007-04-03       Impact factor: 3.415

2.  General Anesthesia for Patients With Chronic Obstructive Pulmonary Disease and Postoperative Respiratory Failure: A Retrospective Analysis of 120 Patients.

Authors:  Ruixue Hou; Fangfang Miao; Di Jin; Qingfang Duan; Cheng Yin; Qunpeng Feng; Tianlong Wang
Journal:  Front Physiol       Date:  2022-05-30       Impact factor: 4.755

3.  Value of preoperative 6-minute walk test for predicting postoperative pulmonary complications.

Authors:  Warangkana Keeratichananont; Chokchai Thanadetsuntorn; Suriya Keeratichananont
Journal:  Ther Adv Respir Dis       Date:  2015-11-06       Impact factor: 4.031

4.  Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer.

Authors:  Melissa A L Vyfhuis; Neha Bhooshan; Whitney M Burrows; Michelle Turner; Mohan Suntharalingam; James Donahue; Elizabeth M Nichols; Josephine Feliciano; Søren M Bentzen; Shahed Badiyan; Shamus R Carr; Joseph Friedberg; Charles B Simone; Martin J Edelman; Steven J Feigenberg; Pranshu Mohindra
Journal:  Adv Radiat Oncol       Date:  2017-07-31

5.  Surgery for early-stage small cell lung cancer: is it worth it?

Authors:  Melissa A L Vyfhuis; Pranshu Mohindra; Charles B Simone
Journal:  Mediastinum       Date:  2019-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.